Vivoryon Therapeutics N.V.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vivoryon Therapeutics N.V.
Vivoryon Therapeutics NV is a clinical-stage biopharmaceutical company focused on discovering, developing, and potentially commercializing small-molecule-based medicines that modulate the activity and stability of pathologically altered proteins. Vivoryon is currently focused on developing treatments for chronic kidney disease (CKD), and more precisely, is initially targeting stage 3b and worse diabetic kidney disease (DKD). Its product pipeline includes various drug candidates, including varoglutamstat (PQ912), VY2149, and NCE, as potential treatments for chronic kidney disease (CKD), and more precisely, are initially targeting stage 3b and worse diabetic kidney disease (DKD). The company is also pursuing antibody-based approaches for Alzheimer’s disease.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Vivoryon Therapeutics N.V. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vivoryon Therapeutics N.V. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vivoryon Therapeutics N.V. is VVY:xams. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vivoryon Therapeutics N.V. has its primary listing on Euronext Amsterdam. You can trade Vivoryon Therapeutics N.V. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vivoryon Therapeutics N.V. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vivoryon Therapeutics N.V. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vivoryon Therapeutics N.V..